Cardiovascular disease (CVD) kills 1 in 3 women worldwide, and the risk of SCD increases markedly after the cessation of ovatina function at menopause.
Cardiovascular disease (CVD) kills 1 in 3 women worldwide, and the risk of SCD increases markedly after the cessation of ovatina function at menopause.